Trellis SessionStart ✓

I'll begin by reading the initial read set files to understand the assignment context.

Context loaded. I'm worker_01 — assigned to read-only verification of source relationships for package 76 (body.p980-p984) vs packages 77-80 (body.p985-p1024), Phase II process table safety items, existing process catalogs, and the official enrollment/exclusion matrix. Let me explore the source artifacts.

Now let me examine the frozen phase plan to understand the package structure, particularly package 76 and packages 77-80.

Now let me extract package 76 and packages 77-80 from the frozen plan.

Package order doesn't match numbering. Let me find package 76 by its ID `pap-02ff890bf007aae9a89887a8` and inspect the package structure.

Package 76 owns exactly 5 units: `body.p980` (安全性评估), `p981` (安全性指标), `p982` (AE/TEAE/SAE发生率 list item), `p983` (常规安全性参数 list item), `p984` (术语定义). Now let me read the verbatim source text from the frozen structure blob.

Now let me extract the verbatim text of body.p980-p1024 and the Phase II process table (t5).

Package 76's five owned units and packages 77-80's span (p985-p1024) are now clear. Let me verify the exact ownership boundaries of packages 77-80 in the frozen plan.

Ownership boundaries confirmed: pkg 77 = p985-p994 (AE+TEAE), pkg 78 = p995-p1006 (SAE), pkg 79 = p1007-p1014 (SAE criteria cont.), pkg 80 = p1015-p1026 (ADR/SUSAR/AE收集记录). Now let me extract the Phase II process table (body.t5) safety items and heading paths of the 术语定义 subtree.

Table cell refs use a different convention. Let me inspect the t5 block structure.

Full Phase II table (t5) extracted — key safety rows: 生命体征(r10), 体格检查(r11), 血/尿/生化/凝血(r12-15), 12-导联心电图(r21), 不良事件^26(r38) which starts at W0/D1 (治疗期), not screening. Let me check the footnote for ^26 and the coverage manifest structure units.

p885 is the 基线^2 footnote confirming D1 baseline re-check of I/E criteria plus 合并用药及不良事件 record start. Now let me get the ^26 footnote text directly from the read-only source docx.

No footnotes.xml — the ^26 footnote text must be inline in the body. Let me search all footnote_or_annotation units in the manifest.

Found it: p340 defines 不良事件 recording start at D1 dose; p341 defines 提前退出. Now let me examine the procedure catalog and official I/E matrix.

Key finding: the procedure catalog (50 items) excludes 不良事件 (t5.r38) and treatment-only rows. Now let me list the official I/E matrix rows to confirm no safety-summary/AE rows are screening/baseline controls.

The matrix confirms: no AE/TEAE/SAE/safety-summary rows among the 58 controls — row 58 (合并治疗) is the last procedure control, scoped to screening→first dose. Now let me verify manifest structure units for p980-p1026 heading paths and phase scopes.

Full subtree mapped. Let me confirm the section numbering from the TOC and check the manifest's `dispositions` plus where the 安全性评估 section ends.

Section numbers confirmed: 7.3 安全性评估 (p980), 7.3.1 安全性指标, 7.3.2 术语定义, 7.3.3 不良事件的收集和记录. Let me check downstream packages 81-84 to complete the read-only boundary map.

Downstream packages 81-84 continue chapter 7.3 (记录与规定, 评估, 报告). Let me check the full package schema for any boundary/read-only fields, and check package 76's context_units relation to p985+.

No span overlap between p76 and p77-80 — clean ownership boundary. Let me do a final grep across the control matrix and procedure catalog for any AE/safety-summary leakage as controls.

Row 57's AE mention traces to the p885 anchor (baseline review footnote) — incidental, not an AE control. Let me check the 7.1 chapter (研究期间的检查和评估) range that owns the routine safety parameter details, to complete the cross-reference map.

p835 (pkg 75) contains an explicit forward reference: "不良事件的收集详见'7.3.3.不良事件的收集和记录'". Let me do a final check of diff-qc.json and the summary-side p340/p341 ownership, then compile the report.

All verification complete — no files modified. I have full evidence for the source-relationship map. Here is the report.

# Execution Output: phase5-slice61bn-package76-safety-summary-boundary - worker_01

## Boundary And Context Check

- Role: `worker_01`, finite read-only verification executor. No execution manager; Codex reviews directly.
- Hard boundary respected: **zero file writes**; all checks were read-only (python3 JSON/zipfile inspection of frozen artifacts, manifest, plan, procedure catalog, control matrix).
- Initial read set loaded: `context/phase5-slice61bn-package76-safety-summary-boundary_execution_context.md`, `plans/codex_execution_phase5-slice61bn-package76-safety-summary-boundary.md`.
- Additional evidence read (within workspace): `frozen_phase_plan.json`, `coverage_manifest.json`, `freeze_metadata.json`, `diff-qc.json`, protocol blocks blob `3946ea2c…2343d.json`, read-only source docx (zip listing + `word/document.xml` metadata check, no footnotes part), `required_procedures.json` (slice61bl), `d001-ii-official-flow-controls.json` + `d001-ii-control-matrix.json` (row 57 anchors).
- Assigned work item #1 only. Items #2 (worker_02) and #3 (worker_03) not executed.

## Work Performed

**1. Confirmed package 76 ownership (frozen plan, `pap-02ff890bf007aae9a89887a8`, ordinal 76).** Exactly 5 owned units (`body.p980-p984`), all `study_phase=phase_ii`, all `phase_scopes=['unknown']`:

| Owned unit | Kind | Section (TOC) | Verbatim content |
|---|---|---|---|
| `body.p980` | paragraph (heading) | 7.3 安全性评估 | 安全性评估 |
| `body.p981` | paragraph (heading) | 7.3.1 安全性指标 | 安全性指标 |
| `body.p982` | list_item | 7.3.1 | 不良事件、治疗期出现的不良事件和严重不良事件的发生率； |
| `body.p983` | list_item | 7.3.1 | 常规安全性参数，包括实验室检查、生命体征测量、12导联心电图（ECG）和体格检查等。 |
| `body.p984` | paragraph (heading) | 7.3.2 术语定义 | 术语定义 |

30 context units (phase II/III flow-table header rows, endpoints, design, visit-schedule headings, statistics headings); 61 frozen spans. **No span overlap** with packages 77-80 owned spans (verified set intersection = ∅). `diff-qc.json` shows the plan was accepted post-rebaseline (`accepted: true`).

**2. Semantic disposition of each owned unit (evidence-based).**
- `p980/p981` are chapter/sub-chapter headings of **7.3 安全性评估**, an analysis/monitoring chapter — not an enrollment-control chapter. The control chapters are 7.1 研究期间的检查和评估 (procedures, owned by pkgs 67-72: 7.1.5 生命体征 p784, 7.1.6 体格检查 p787, 7.1.7 ECG p789, 7.1.9 实验室 p798) and 7.2 访视安排 (p838+, pkgs 73-76). 7.3 = summary/definitions.
- `p982` = **treatment-period safety endpoint summary** (AE/TEAE/SAE 发生率). The terms it cites are defined downstream in 7.3.2 (p985-p1019, owned by pkgs 77-80). `p982` itself creates no procedure, no evidence obligation, no gate.
- `p983` = **routine safety parameter summary dimension**. The same parameter names are performed/controlled earlier: process table t5 rows r10(生命体征), r11(体格检查), r12-15(血/尿/生化/凝血), r21(12-导联ECG) carry screening `X` + baseline `(X)` marks and are the anchors of official-matrix controls rows 42-47, 53. `p983` references them as analysis dimensions; it does not add new obligations.
- `p984` = heading of the definition subtree 7.3.2 whose children (`p985-p1019`) are **owned by pkgs 77-79**. Package 76 must render `术语定义` as a placeholder/heading only, never expand definitions.

**3. Phase II process table (t5) safety items verified.**
- 生命体征 r10, 体格检查 r11, 血常规 r12, 尿常规 r13, 血生化 r14, 凝血 r15, 妊娠/FSH r16, 12-导联ECG r21: screening `X` + baseline `(X)` + treatment columns.
- **不良事件 r38: only treatment column (W0/D1) `X`; screening and baseline cells are blank** — AE recording starts at D1, matching summary footnote `p340` ("不良事件于D1启动给药后开始记录，直至末次安全性随访或者退出研究为止") and detailed `p1022` (pkg 80).
- 合并治疗 r37: screening `X` (collection from ICF, p339/p837). 入排标准审核 r27: screening `X`, baseline `(X)`, W0 `X`.
- Footnote ^26 markers confirmed on 治疗期/提前退出/不良事件 cells; footnote content is inline body paragraphs (no `footnotes.xml` in source docx).

**4. Existing procedure catalog (slice61bl, 50 items) verified.** Includes 生命体征/体格检查/实验室/ECG/合并治疗 at screening+baseline; **excludes 不良事件 (t5.r38), 随机, PK, IP管理, 日记卡, 依从性**. Keyword scan for 不良事件/AE/TEAE/SAE/安全性/ADR/SUSAR/发生率 in the catalog: **zero hits** — the catalog already respects the boundary.

**5. Official I/E matrix verified (58 rows, `claims_complete: false`).** Rows 1-36 = I/E criteria; rows 37-58 = screening/baseline required procedures with evidence specs. **No row encodes AE/TEAE/SAE/安全性指标/安全性评估/发生率 as a control.** The only "不良事件" keyword hit is row 57's source anchor `pcm-src-8524c6fa…` → `body.p885` (基线复核 footnote: "…同时需要记录合并用药及不良事件"), which is the 入排审核 control's incidental mention of D1 recording start — not an AE gate. Row 58 (合并治疗) is the last procedure control, scoped "筛选至首次给药前" — consistent with p1023 (pre-dose events → 病史/伴随疾病, not AE).

**6. Read-only boundary for packages 77-80 (p985+) established.**
- **pkg 77** `pap-11233226bef34c28a4a2e05c`: `p985-p994` — 7.3.2.1 不良事件（AE）定义 + "不应作为AE记录" 5 items (**p988**: 筛选时发现的已存在情况→病史/伴随疾病; **p989-p992** 计划住院/侵入检查/预期进展/预期波动) + 7.3.2.2 TEAE (`p993-p994`).
- **pkg 78** `pap-d01122f016611fda097bbad0`: `p995-p1006` — 7.3.2.3 SAE 定义、6项严重标准、住院例外前7条.
- **pkg 79** `pap-5fbec1c2327b345382aa22d6`: `p1007-p1014` — SAE 住院例外 8-14 条、先天异常、其他重要医学事件.
- **pkg 80** `pap-bb9bf95c9cd13f15e3b737f3`: `p1015-p1026` — ADR、SUSAR、7.3.3 不良事件的收集和记录 (`p1020-p1024`: 收集期=首剂至末次安全随访/退出; ICF后至首剂前→病史/伴随疾病不作为AE; 首剂至末次访视AE均入eCRF) + 记录与规定 (`p1025-p1026`).
- Downstream beyond the four: pkg 81+ owns 7.3.3.2 续(诊断与症状、体征和检查值 p1027+, 继发事件, 持续性/复发性, 实验室异常 p1037+), 7.3.4 评估, 7.3.5 报告, 7.3.6 随访.

**7. Cross-references confirming the boundary.**
- `p835` (owned by **pkg 75**, 7.1.16 记录不良事件): "整个研究过程要严密监测参与者的不良事件…不良事件的收集详见'7.3.3.不良事件的收集和记录'" — explicit forward reference from 7.1 to pkg 80's content; p76/p77-80 must keep it dangling or resolve via pkg 80.
- `p885` (基线^2 footnote, pkg 76 context): D1 baseline re-review of I/E criteria + 记录合并用药及不良事件 start.
- `p340/p341` (summary footnotes) are context-only units in pkgs 31/35 — not owned units in the frozen plan.

## Artifacts And Evidence

- `frozen_phase_plan.json`: package 76 object (5 owned units, 30 context units, 61 frozen spans); packages 74/75/77-84 owned-unit listings; batch packing policy `adjacent_small_heading_runs`, `max_owned_units_per_batch: 12`.
- `coverage_manifest.json`: structure units for `p978-p1026` (heading paths confirm 7.3 subtree: p980→7.3, p981→7.3.1, p984→7.3.2, p985+→7.3.2.x, p1020→7.3.3; all `phase_scopes=['unknown']`); footnote units incl. `p885`, `p1033`, t14.r7.
- Protocol blocks blob: verbatim text of `p975-p1030`, full t5 table rows r0-r38, TOC entries `p215-p245` (7.3.x), `p184-p194` (7.1.x), p340/p341 footnotes, p835 forward ref.
- `required_procedures.json`: 50 items (labels/stages/source refs listed; no safety-summary/AE items).
- `d001-ii-official-flow-controls.json` (58 rows) + `d001-ii-control-matrix.json` (row 57 anchors verbatim).
- `freeze_metadata.json`, `diff-qc.json` (`accepted: true`).

## Commands And Observations

- `python3` JSON inspection of the frozen plan, manifest, blob, catalogs, matrix — all read-only; no installs; no network.
- `zipfile` listing of the read-only source docx: contains `word/document.xml`, headers/footers, no `footnotes.xml` — ^n markers are inline body text (footnote text lives in body paragraphs p315-p345 / p856-p885).
- Observed matrix `claims_complete: false` and rows 7-36 lacking `attainment_criteria_zh` — pre-existing upstream gap, out of this slice's scope (flag only).

## Blockers Or Missing Environment

- None. All required sources existed and were consistent. No environment or tool missing.

## Rerun Requests Or Next Step

- No rerun needed for worker_01. Hand-off suggestions for Codex:
  1. **worker_02** may build the source-closure config on exactly the 5 owned units (`p980-p984`) + read-only closure `p985-p1026` (+ p340/p341/p835/p885 as cross-ref evidence), with a gate blocking any of: AE/TEAE/SAE 发生率 (`p982`), 常规安全性参数 (`p983`), 术语定义 subtree (`p985-p1019`) from becoming screening/baseline obligations.
  2. **worker_03** may use the verified boundary facts (t5.r38 D1-only mark; p988/p1023 AE-vs-病史 split; matrix rows 37-58 lacking any safety-summary row; p984 heading owned by p76 but subtree by p77-79; p835 forward ref to pkg 80) as acceptance criteria anchors.
  3. Note for the closure config: `p983`'s parameter names legitimately overlap with matrix controls rows 42-47/53 — the guard must distinguish "summary dimension mention" from "new obligation" (allow the former, block the latter).
  4. Residual verification need (Codex authority): confirm the same boundary holds for the phase-III projection (`opposite_phase: phase_iii`) when package 76's sibling III-side packages are processed, and whether `claims_complete=false` rows 7-36 need a separate remediation slice.
